Menstrual Cycle
63
24
26
22
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 63 trials
95.7%
+9.1% vs benchmark
0%
0 trials in Phase 3/4
9%
2 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (63)
Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation
The Effects of Postbiotic Supplementation in Female Athletes
Effects of Menstrual Cycle Phases on Gait, Pelvis, and Sleep
Effects of the Menstrual Cycle and Oral Contraceptive Use on Health and Performance in Athletes
Eccentric Exercise, Muscle Damage, and Oxygen Uptake Across Menstrual Cycle Phases
Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
Identification and Validation of Epigenetic Biomarkers of PMDD
Phenylalanine Requirements in the Menstrual Phases
Menstrual Status, Anesthetic Consumption, and PONV
Effects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery
The Effects of Menstrual Cycle Phase on Exercise Treadmill Test Results in Premenopausal Women
My MS and My Menstrual Cycle
Effects of Antipsychotics on Brain Insulin Action in Females
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
Menstrual Cycle and Women's Performance
Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting
Leucine Requirements During the Menstrual Cycle
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise